218 related articles for article (PubMed ID: 22447734)
1. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study.
Muller M; van der Graaf Y; Visseren FL; Mali WP; Geerlings MI;
Ann Neurol; 2012 Jun; 71(6):825-33. PubMed ID: 22447734
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.
van der Veen PH; Muller M; Vincken KL; Hendrikse J; Mali WP; van der Graaf Y; Geerlings MI;
Stroke; 2015 May; 46(5):1233-8. PubMed ID: 25804924
[TBL] [Abstract][Full Text] [Related]
3. Total cerebral blood flow and hippocampal volume in patients with arterial disease. The SMART-MR study.
Knoops AJ; van der Graaf Y; Appelman AP; Mali WP; Geerlings MI
J Cereb Blood Flow Metab; 2009 Oct; 29(10):1727-33. PubMed ID: 19675562
[TBL] [Abstract][Full Text] [Related]
4. Blood Pressure Is Not Associated With Cerebral Blood Flow in Older Persons.
Foster-Dingley JC; Moonen JE; de Craen AJ; de Ruijter W; van der Mast RC; van der Grond J
Hypertension; 2015 Nov; 66(5):954-60. PubMed ID: 26351027
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal MR imaging study in the prediction of ischemic susceptibility after cerebral hypoperfusion in rats: Influence of aging and hypertension.
Lee JT; Liu HL; Yang JT; Yang ST; Lin JR; Lee TH
Neuroscience; 2014 Jan; 257():31-40. PubMed ID: 24188793
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study.
Muller M; van der Graaf Y; Visseren FL; Vlek AL; Mali WP; Geerlings MI;
J Hypertens; 2010 Jul; 28(7):1498-505. PubMed ID: 20453669
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and progression of brain atrophy: the SMART-MR Study.
Jochemsen HM; Muller M; Visseren FL; Scheltens P; Vincken KL; Mali WP; van der Graaf Y; Geerlings MI;
JAMA Neurol; 2013 Aug; 70(8):1046-53. PubMed ID: 23753860
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
9. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study.
Appelman AP; van der Graaf Y; Vincken KL; Tiehuis AM; Witkamp TD; Mali WP; Geerlings MI;
J Cereb Blood Flow Metab; 2008 Mar; 28(3):633-9. PubMed ID: 17912270
[TBL] [Abstract][Full Text] [Related]
10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure and the brain: a 5-year follow-up.
Goldstein IB; Bartzokis G; Guthrie D; Shapiro D
Neurology; 2005 Jun; 64(11):1846-52. PubMed ID: 15955932
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of cerebral hypoperfusion and white matter lesions on executive functioning - The SMART-MR study.
Appelman AP; van der Graaf Y; Vincken KL; Mali WP; Geerlings MI
Dement Geriatr Cogn Disord; 2010; 29(3):240-7. PubMed ID: 20375504
[TBL] [Abstract][Full Text] [Related]
14. Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function: The Second Manifestations of Arterial Disease-Magnetic Resonance Study.
van der Veen PH; Geerlings MI; Visseren FL; Nathoe HM; Mali WP; van der Graaf Y; Muller M;
Hypertension; 2015 Dec; 66(6):1152-8. PubMed ID: 26503971
[TBL] [Abstract][Full Text] [Related]
15. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities.
ten Dam VH; van den Heuvel DM; de Craen AJ; Bollen EL; Murray HM; Westendorp RG; Blauw GJ; van Buchem MA
Radiology; 2007 Apr; 243(1):198-203. PubMed ID: 17329688
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
17. Local chronic hypoperfusion secondary to sinus high pressure seems to be mainly responsible for the formation of intracranial dural arteriovenous fistula.
Chen L; Mao Y; Zhou LF
Neurosurgery; 2009 May; 64(5):973-83; discussion 983. PubMed ID: 19404157
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
20. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
